CSTONE PHARMA-B is listed in Hong Kong. Sector: Healthcare. Industry: Biotechnology.
CSTONE PHARMA-B (02616): research close 5.46 HKD on 2026-11-17. 52-week range 4.19 to 10.23 HKD. Sector: Healthcare. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 5.46 HKD | 2026-11-17 |
| Previous research close | 5.16 HKD | 2026-11-16 |
| Change between the two dated research closes | 5.92% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 8.72 billion HKD | 2026-11-17 |
| 52-week range of the research close | 4.19 – 10.23 HKD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | -5.04% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 32.41 million HKD | 2026-11-17 |
Source: hk_prices_research_v1 · HK · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save 02616 to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate